Advertisement

Topics

Merz Pharmaceuticals USA Company Profile

05:21 EDT 26th September 2017 | BioPortfolio

A total of nine experts from around the world trained in multiple specialties (dermatology, ophthalmology, plastic surgery, and dermatologic surgery) came together to create and validate a comprehensive scale system, reviewing and including photographs of men and women of diverse ages, skin types and ethnicities. As part of this process, the experts rated 35 to 50 real-life images of people, and evaluated the images for reproducibility of results.


News Articles [1283 Associated News Articles listed on BioPortfolio]

Merz nabs Allergan exec to head US neurosciences business

Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join the…

Allergan Veteran Kevin O’Brien Moves to Merz to Lead Neurosciences

Kevin O’Brien, a 16-year veteran of Allergan (NYSE: AGN), is joining Merz North America as vice president and U.S. head of neurosciences. O’Brien had held various roles in Allergan’s dermatology...

Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products

FRANKFURT, Germany, April 8, 2013 /PRNewswire/ -- Merz Pharma Group ("Merz" or "the Company") today announced that it has withdrawn its non-binding proposal to acquire all of the outstanding comm...

Merz Neurosciences Announces Positive Phase III Results of Xeomin® (IncobotulinumtoxinA) for Sialorrhea at 2017 MDS Meeting

Wednesday, June 7th 2017 at 6:00pm UTC RALEIGH, N.C.–(BUSINESS WIRE)– Merz Neurosciences, a division of Merz North America, announced today positive topline results from its pivotal Phase ...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 02052017] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 12062017] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz Announces Kevin O’Brien as Vice President and U.S. Head of Neuroscience Business

Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join as the Vice President and U.S. Head of Neurosciences, effective immediately. Mr...

Merz’s Xeomin meets in Phase III trial for PD-associated sialorrhea

PubMed Articles [156 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Clinical Trials [200 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation

Primary objective: - To evaluate the sensitivity of the Merz Lip Fullness Assessment Scale (MLFAS). Secondary objectives: - To evaluate the clinical aesthetic improvement outco...

The Influence of Glutamate on Memory in Humans

The hippocampus is particularly laden with n-methyl-d-aspartate (NMDA) receptors, and is at the same time one of the most important sites in declarative memory. The rationale of this study...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1288 Associated Companies listed on BioPortfolio]

Merz Pharmaceuticals

Merz Pharmaceuticals, LLC is a part of Merz, Inc., a wholly owned U.S. subsidiary of the Merz Group of Companies and was established in 1995 to develop and commercialize products for the Merz Group. ...

Merz Pharmaceuticals GmbH and DiaGenic ASA

Merz Pharmaceuticals researches, develops, produces and distributes innovative pharmaceutical products in the areas of neurology and psychiatry as well as in aesthetic dermatology and metabolism. ...

Merz Pharma Canada Ltd.

Merz Pharma Canada Ltd. a wholly owned subsidiary of the Merz Group of Companies was established in 2009 to expand Merz franchises in the Canadian Marketplace.

Merz Aesthetics

Merz Aesthetics, the new business unit of Merz Pharma Group, is a leader in the global aesthetic medicine market. With a 100-year history of compassion and innovation in healthcare, Merz Aesthetics i...

Merz Pharma Group Merz Pharma Group

The Merz Pharma Group’s focus is on drugs for treating neurological and psychiatric conditions and the group holds a leading position in the field of Alzheimer’s researc...

More Information about "Merz Pharmaceuticals USA" on BioPortfolio

We have published hundreds of Merz Pharmaceuticals USA news stories on BioPortfolio along with dozens of Merz Pharmaceuticals USA Clinical Trials and PubMed Articles about Merz Pharmaceuticals USA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merz Pharmaceuticals USA Companies in our database. You can also find out about relevant Merz Pharmaceuticals USA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...


Corporate Database Quicklinks



Searches Linking to this Company Record